BioCentury
ARTICLE | Company News

Orexo regains ex-U.S. rights to Zubsolv from Mundipharma

December 21, 2018 7:27 PM UTC

Orexo AB (SSE:ORX) will regain global, ex-U.S. rights to Zubsolv buprenorphine/naloxone from Mundipharma International Ltd. (Dublin, Ireland), effective April 13. Orexo, which holds U.S. rights to the drug, said the news follows a portfolio reorganization by Mundipharma...